REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Umang Cure Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Umang Cure Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Umang Cure Private Limited is an unlisted company, incorporated on 03/09/1996. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U45201DL1996PTC081645 and registration number is 081645. The company is a trade company, it is engaged in wholesale trading.

Legal Address
A-213, Shanti Gopal Chamber, Vikas Marg, Shakarpur,
East Delhi; Delhi; Postal Code: 110092

Contact Details: Purchase the Umang Cure Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Umang Cure Private Limited report to view the information.
Outstanding Shares:
Purchase the Umang Cure Private Limited report to view the information.
Registered Capital:
Purchase the Umang Cure Private Limited report to view the information.
Incorporation Date:
September 03, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
57.5%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Umang Cure Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
45.2%▲
Total operating revenue
45.22%▲
Operating profit (EBIT)
63.31%▲
EBITDA
59.62%▲
Net Profit (Loss) for the Period
63.61%▲
Total assets
39.22%▲
Total equity
27.51%▲
Operating Profit Margin (ROS)
0.18%▲
Net Profit Margin
0.13%▲
Return on Equity (ROE)
4.8%▲
Debt to Equity Ratio
12.94%▲
Quick Ratio
-0.03%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo